VISTAGEN THERAPEUTICS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $2.92 million for the 12-month period ending 2021-03-31, per its 10-K filed 2021-06-29.
Discontinued › Notes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2021-06-29
- VISTAGEN THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $2.92M, a 30.47% decline from fiscal 2020.
- VISTAGEN THERAPEUTICS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $4.20M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2021-03-31 | $2.92M 10-K · filed 2021-06-29 |
| 2020-03-31 | $4.20M 10-K · filed 2021-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |